Exosomal miRNA-148b/301a/423 cluster predicts pneumonitis risk in NSCLC with concurrent radiotherapy with immunotherapy via PTPN14-YAP signaling: a retrospective cohort study
BackgroundRadiotherapy (RT) combined with Immune checkpoint inhibitors (ICIs) significantly improve outcomes in non-small cell lung cancer (NSCLC), yet this combination amplifies treatment-related pneumonitis risk. The real-world incidence, predictive biomarkers, and underlying pathogenesis of RT-IC...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-09-01
|
| Colección: | Frontiers in Immunology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1666946/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|